Marketing-authorisation holder · Canada
Formative Pharma Inc.
16 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
16 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BIVALIRUDIN FOR INJECTION250 mg / vial · Powder For Solution | Bivalirudin | Canada | Marketed | 2024 |
| BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP7.5 mg / ml · Solution | Bupivacaine | Canada | Marketed | 2024 |
| BUPIVACAINE HYDROCHLORIDE INJECTION USP5 mg / ml · Solution | Bupivacaine | Canada | Authorised | |
| BUPIVACAINE HYDROCHLORIDE INJECTION USP2.5 mg / ml · Solution | Bupivacaine | Canada | Authorised | |
| CABAZITAXEL FOR INJECTION45 mg / 4.5 ml · Solution | Cabazitaxel | Canada | Marketed | 2025 |
| CABAZITAXEL FOR INJECTION60 mg / 6 ml · Solution | Cabazitaxel | Canada | Marketed | 2025 |
| CYCLOPHOSPHAMIDE FOR INJECTION USP1000 mg / vial · Powder For Solution | Cyclophosphamide | Canada | Authorised | |
| CYCLOPHOSPHAMIDE FOR INJECTION USP500 mg / vial · Powder For Solution | Cyclophosphamide | Canada | Authorised | |
| CYCLOPHOSPHAMIDE FOR INJECTION USP2000 mg / vial · Powder For Solution | Cyclophosphamide | Canada | Authorised | |
| FULVESTRANT INJECTION250 mg / 5 ml · Solution | Fulvestrant | Canada | Marketed | 2023 |
| GANCICLOVIR FOR INJECTION500 mg / vial · Powder For Solution | Ganciclovir | Canada | Marketed | 2023 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP10 mg / ml · Solution | Lidocaine | Canada | Marketed | 2024 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP20 mg / ml · Solution | Lidocaine | Canada | Marketed | 2025 |
| SUGAMMADEX INJECTION100 mg / ml · Solution | Sugammadex | Canada | Authorised | |
| VORICONAZOLE FOR INJECTION200 mg / vial · Powder For Solution | Voriconazole | Canada | Authorised | |
| XFUSOR2 mg / ml · Solution | Ropivacaine | Canada | Authorised |